Infinity Pharma Stock Price (NASDAQ:INFI)

Add to My Stocks
$3.39 $0.09 (2.73%) INFI stock closing price Mar 27, 2017 (Closing)
Prev Close* : $3.30
Market Cap:
Day Low: $3.17
52 Week Low: $0.84
Open: $3.23
Volume: 572941
Day High: $3.42
52 Week High: $6.63

Latest Stock Market News

Latest Articles

Infinity Pharma News - From Partners

INFI Stockcharts

View INFI PE ratio, PS ratio stocks charts and compare with peers.
INFI Chart
Note: Compare Infinity Pharma stock price history with the index and industry peers.

Infinity Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Infinity Pharma Financial Ratios

Debt to Equity

INFI Industry Peers

Company Price Change (%)
Glycomimetics (GLYC)5.660.1 (1.8%)
Acelrx Pharma (ACRX)3.050.03 (0.97%)
Abbvie (ABBV)66.10.48 (0.73%)
Tg Therapeutics (TGTX)11.650.25 (2.19%)
Celgene (CELG)124.861.48 (1.2%)
Seattle Genetics (SGEN)64.390.7 (1.1%)
Bristol-myers Squibb (BMY)56.040.15 (0.27%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Catalyst Pharma (CPRX)2.010.31 (18.24%)
Aralez Pharma (ARLZ)2.420.23 (10.5%)
Rigel Pharma (RIGL)3.430.3 (9.58%)
Flexion Therapeutics (FLXN)29.261.99 (7.3%)
Cempra (CEMP)4.350.25 (6.1%)
Endo International (ENDP)10.50.53 (5.32%)
Corcept Therapeutics (CORT)10.650.53 (5.24%)
Top gainers from Medical-Drugs industry
* As of Mar 28, 2017
CompanyPriceChange (%)
Redhill Biopharma (RDHL)10.230.24 (2.29%)
Tesaro Inc (TSRO)156.733.27 (2.04%)
Esperion Therapeutics (ESPR)38.270.67 (1.72%)
Ignyta (RXDX)9.150.1 (1.08%)
AcelRx Pharma (ACRX)3.050.03 (0.98%)
Xencor (XNCR)24.30.23 (0.94%)
La Jolla Pharma (LJPC)34.630.29 (0.83%)
Top losers from Medical-Drugs industry
* As of Mar 28, 2017

Infinity Pharmaceuticals Inc. Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Infinity Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues109.06M164.99M-47.11M92.77M
Net Income-128.37M-17.41M-126.78M-53.96M-40.04M
Total Operating Expense236.16M172.91M127.67M99.92M131.29M
view Infinity Pharmaceuticals Inc. income statement
balance sheet20152014201320122011
Total Assets288.82M369.14M230.71M335.66M124.49M
Total Liabilities190.26M159.67M29.43M25.45M109.05M
Shareholders Equity98.55M209.47M201.27M310.2M15.43M
view Infinity Pharmaceuticals Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities26.97M109.57M-3.71M-39.39M-3.28M
Net Cash From (Used By) Operating Activities-83.65M117.71M-113.9M-80.13M-33.1M
Increase (Decrease) In Prop Plant And Equipment-6.42M-1.36M-1.75M-1.3M-1.54M
view Infinity Pharmaceuticals Inc. cashflow statement

Infinity Pharma Stock Message Board

Infinity Pharma stock lost 2.73 %, and the last close price as of 27 Mar, 2017 is 3.39 for INFI stock. The total market value as denoted by 166.41M for Infinity Pharma, is the market value of the company's outstanding shares. Infinity Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy INFI stock than sell it, then Infinity Pharma stock price goes up. Conversely, if more investors wanted to sell INFI stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 572941 on the last trading day, as is evident from Infinity Pharma stock chart, and INFI stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Infinity Pharma does not pay dividends. One can observe stock price trends and check for volatility by checking Infinity Pharma stock price history.